These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37471116)

  • 1. Population structure, serotype distribution and antibiotic resistance of
    Higgs C; Kumar LS; Stevens K; Strachan J; Sherry NL; Horan K; Zhang J; Stinear TP; Howden BP; Gorrie CL
    Microb Genom; 2023 Jul; 9(7):. PubMed ID: 37471116
    [No Abstract]   [Full Text] [Related]  

  • 2. Population genetic structure, serotype distribution and antibiotic resistance of
    Gagetti P; Lo SW; Hawkins PA; Gladstone RA; Regueira M; Faccone D; Sireva-Argentina Group ; Klugman KP; Breiman RF; McGee L; Bentley SD; Corso A
    Microb Genom; 2021 Sep; 7(9):. PubMed ID: 34586054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CIRCULATING CLONAL COMPLEXES AND SEQUENCE TYPES OF STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A WORLDWIDE: THE IMPORTANCE OF MULTIDRUG RESISTANCE: A SYSTEMATIC LITERATURE REVIEW.
    Ruiz García Y; Nieto Guevara J; Izurieta P; Vojtek I; Ortega-Barría E; Guzman-Holst A
    Expert Rev Vaccines; 2021 Jan; 20(1):45-57. PubMed ID: 33507135
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Nagaraj G; Govindan V; Ganaie F; Venkatesha VT; Hawkins PA; Gladstone RA; McGee L; Breiman RF; Bentley SD; Klugman KP; Lo SW; Ravikumar KL
    Microb Genom; 2021 Sep; 7(9):. PubMed ID: 34494953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotype Distribution and Antimicrobial Resistance of
    Kim GR; Kim EY; Kim SH; Lee HK; Lee J; Shin JH; Kim YR; Song SA; Jeong J; Uh Y; Kim YK; Yong D; Kim HS; Kim S; Kim YA; Shin KS; Jeong SH; Ryoo N; Shin JH
    Ann Lab Med; 2023 Jan; 43(1):45-54. PubMed ID: 36045056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive/colonization isolates of Streptococcus pneumoniae: A cross-sectional study eight years after the licensure of conjugate vaccine in Japan.
    Kawaguchiya M; Urushibara N; Aung MS; Ito M; Takahashi A; Habadera S; Kobayashi N
    J Infect Public Health; 2020 Aug; 13(8):1094-1100. PubMed ID: 32446777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using genomics to examine the persistence of Streptococcus pneumoniae serotype 19A in Ireland and the emergence of a sub-clade associated with vaccine failures.
    Corcoran M; Mereckiene J; Cotter S; Murchan S; Lo SW; McGee L; Breiman RF; Cunney R; Humphreys H; Bentley SD; Gladstone RA
    Vaccine; 2021 Aug; 39(35):5064-5073. PubMed ID: 34301430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotype changes and antimicrobial nonsusceptibility rates of invasive and non-invasive Streptococcus pneumoniae isolates after implementation of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Bulgaria.
    Setchanova L; Murdjeva M; Stancheva I; Alexandrova A; Sredkova M; Stoeva T; Yoneva M; Kurchatova A; Mitov I
    Braz J Infect Dis; 2017; 21(4):433-440. PubMed ID: 28472614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility and clonality of Streptococcus pneumoniae isolates recovered from invasive disease cases during a period with changes in pneumococcal childhood vaccination, Norway, 2004-2016.
    Siira L; Vestrheim DF; Winje BA; Caugant DA; Steens A
    Vaccine; 2020 Jul; 38(34):5454-5463. PubMed ID: 32616324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
    Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from adult patients in Asia: Emergence of drug-resistant non-vaccine serotypes.
    Kim SH; Chung DR; Song JH; Baek JY; Thamlikitkul V; Wang H; Carlos C; Ahmad N; Arushothy R; Tan SH; Lye D; Kang CI; Ko KS; Peck KR;
    Vaccine; 2020 Aug; 38(38):6065-6073. PubMed ID: 31590932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotype distribution and antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates among adult and elderly population before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco.
    Nzoyikorera N; Diawara I; Katfy M; Katfy K; Maaloum F; Nyandwi J; Belabbes H; Elmdaghri N; Zerouali K
    BMC Infect Dis; 2023 Jan; 23(1):24. PubMed ID: 36639755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing trends in serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive diseases in Central Thailand, 2009-2012.
    Phongsamart W; Srifeungfung S; Chatsuwan T; Nunthapisud P; Treerauthaweeraphong V; Rungnobhakhun P; Sricharoenchai S; Chokephaibulkit K
    Hum Vaccin Immunother; 2014; 10(7):1866-73. PubMed ID: 25424794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of 13-Valent Pneumococcal Conjugate Vaccine on the Serotype Distribution and Antibiotic Resistance Profiles in Children With Invasive Pneumococcal Disease.
    Gaviria-Agudelo CL; Jordan-Villegas A; Garcia C; McCracken GH
    J Pediatric Infect Dis Soc; 2017 Sep; 6(3):253-259. PubMed ID: 26907814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole genome characterization of Streptococcus pneumoniae from respiratory and blood cultures collected from Canadian hospitals before and after PCV-13 implementation in Canada: Focus on serotypes 22F and 33F from CANWARD 2007-2018.
    Golden AR; Adam HJ; Baxter M; Martin I; Demczuk W; Mulvey MR; Karlowsky JA; Zhanel GG;
    Vaccine; 2021 Sep; 39(39):5474-5483. PubMed ID: 34454785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
    Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
    Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population structure and drug resistance patterns of emerging non-PCV-13 Streptococcus pneumoniae serotypes 22F, 15A, and 8 isolated from adults in Ontario, Canada.
    Duvvuri VR; Deng X; Teatero S; Memari N; Athey T; Fittipaldi N; Gubbay JB
    Infect Genet Evol; 2016 Aug; 42():1-8. PubMed ID: 27071529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
    Hsu KK; Shea KM; Stevenson AE; Pelton SI;
    Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
    Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
    Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.